Berger, Adam C <br/><br/>
Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.  [electronic resource] 

 -  Annals of surgical oncology  Jul 2004 
 - 644-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1068-9265 
<br/><br/><label>Standard No.: </label>10.1245/ASO.2004.11.025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--blood<br/>CA-19-9 Antigen--blood<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--pathology<br/>Predictive Value of Tests<br/>Prognosis<br/>Retrospective Studies<br/>Survival Analysis